• The Biopharmaceutical Sciences Master’s Program and the 4+1 (BChE/MS) Program, focused on Bioprocess Development, are built on a collaborative and adaptive educational model that engages leading academic, industrial, and government scientists.
  • This informed training uses industry practice and expertise to create a strengthened pipeline that provides students with a holistic understanding of the biopharmaceutical industry, its regulatory frameworks, and the evolution of the industry as it moves into the future.